Germany Diabetes Care Market

The Germany Diabetes Care market size was USD 2.02 Billion in 2022 and is likely to reach USD 3.41 Billion by 2031, expanding at a CAGR of 6% during 2023–2031. The growth of the market is attributed to the reimbursement, price policies, and increasing rate of adoption of new technology.

Diabetes is a group of illnesses characterized by problems with the hormone insulin, which is generated by the pancreas and regulates blood sugar levels. During these situations, either the pancreas does not generate enough insulin or the body is unable to utilize the hormone properly. Diabetes is one of the leading causes of serious complications in most German patients, including heart attacks, strokes, end-stage renal disease, blindness, and amputations of limbs, despite numerous advances and breakthroughs in its diagnostic and treatment procedures. Various digital care solutions have been launched in the country to assist persons with diabetes as the rates of these illnesses have increased. For example, real-time behavioral and metabolic data is increasingly being used to inform patients about their current insulin levels and assist them in making treatment decisions.

Get Free Sample Report

Germany Diabetes Care Market Trends, Drivers, Restraints, and Opportunities

• Increasing number of diabetic patients and increased awareness of diabetes management and control is estimated to fuel the market during the forecast period.

• Rising awareness of diabetes is key factor spurring the market in the coming years.

• High cost of the treatment is expected to hamper the market growth.

• Negative consequences associated with various diabetes treatment devices act as major challenge that can hinder the market expansion in the coming years.

• Introduction of several new medicines, increased international research partnerships, and increased public knowledge about diabetes are anticipated to create lucrative opportunities for the market players.

Scope of Germany Diabetes Care Market Report

The report on the Germany diabetes care market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Germany Diabetes Care Market Segment Insights

The self-monitoring blood glucose segment is projected to hold a major market share

Based on monitoring devices, the Germany diabetes care market is bifurcated into self-monitoring blood glucose and continuous glucose monitoring. The self-monitoring blood glucose segment is expected to represent a key share of the market during the forecast period. The frequency with which glucose levels are checked is determined by the kind of diabetes, which differs from patient to patient. Patients with type 1 diabetes should check their blood glucose levels at frequent intervals in order to monitor their blood glucose levels and modify their insulin dose as needed. When compared to a routine check of glucose levels at defined intervals, modern CGM systems provide a comprehensive picture of blood glucose patterns and trends.

The insulin disposable pens segment is expected to grow at a rapid pace

On the basis of management devices, the Germany diabetes care market is segregated into insulin pumps, insulin disposable pens, insulin syringes, cartridges in reusable pens, and jet injectors. The insulin disposable pens segment is expected to represent a key share of the market during the forecast period. Insulin disposable pens are the most often used insulin devices in Germany. This segment accounts for more than 55% of the market share in the management devices sector and about 13% of the total diabetes care devices market. Insulin cartridges in reusable pens have long been recognized as a necessary addition to insulin pens. These gadgets are thought to be a more advanced form of insulin vials. Majority of insulins are produced in the form of cartridges, making them conveniently accessible. Because of the rising demand for insulin cartridges, most insulin device manufacturers have developed reusable insulin pens that are interoperable with cartridges from multiple insulin manufacturers.

Segments

The Germany diabetes care market has been segmented on the basis of

Monitoring devices

• Self-monitoring Blood Glucose
• Continuous Glucose Monitoring

Management devices

• Insulin Pumps
• Insulin Disposable Pens
• Insulin Syringes
• Cartridges in Reusable Pens
• Jet Injectors

Key Players

• Abbott Diabetes Care
• Medtronic
• Dexcom
• Roche
• Johnson & Johnson

Competitive Landscape

Key players competing in the Germany diabetes care market include Abbott Diabetes Care; Medtronic; Dexcom; Roche; and Johnson & Johnson.

Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.